A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents

Rationale: Hepatocellular carcinoma (HCC) is a challenging disease due to its heterogenous etiology. Several breakthroughs have occurred in treatment of HCC, associated with an enormous number of patent publications for a variety of HCC treatment modalities. As patents can provide valuable informati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yan, Lyu, Liyang, Feng, Ye, Li, Fei, Hu, Yuanjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364461/
https://www.ncbi.nlm.nih.gov/pubmed/34400877
http://dx.doi.org/10.7150/ijms.59930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364461/
https://www.ncbi.nlm.nih.gov/pubmed/34400877
http://dx.doi.org/10.7150/ijms.59930

Ejemplares similares